I: Establishment of production cell lines; cloning and selection strategies. II: Conditions for high performance cultures for the production of biologicals. III: Protein processing. IV: Protein (monoclonal antibody) engineering. V: Regulatory issues, safety and containment. VI: Animal-cell bioreactors: design and scale-up considerations. VII: New developments: clinical studies, tissue engineering, apoptosis and novel applications.